Pyxis Oncology
PYXS · NASDAQ
$1.84+$0.08 (+4.55%)TodayMarket closed ·
Prev close $1.76
Who owns PYXS
Largest institutional holders, from their latest 13F filings
The 10 largest institutions hold 44.9% of PYXS’s shares.
- GordonMD Global Investments LP12.1%
- BVF Partners L.P.9.5%
- Pfizer Inc.8.5%
- Laurion Capital Management LP5.9%
- Next 6 largest institutions8.9%
- All other shareholders55.1%
| Holder | Shares | % of shares |
|---|---|---|
| GordonMD Global Investments LP | 10.02M | 12.08% |
| BVF Partners L.P. | 7.84M | 9.45% |
| Pfizer Inc. | 7.03M | 8.48% |
| Laurion Capital Management LP | 4.90M | 5.91% |
| Vanguard Capital Management, LLC | 2.08M | 2.50% |
| Sullivan (Lara S. M.D.) | 1.87M | 2.25% |
| Healthinvest Partners AB | 966.46K | 1.16% |
| Palo Alto Investors LP | 864.28K | 1.04% |
| Marshall Wace LLP | 830.54K | 1.00% |
| BlackRock Institutional Trust Company, N.A. | 814.41K | 0.98% |
Largest mutual fund holders
| Holder | Shares | % of shares |
|---|---|---|
| Vanguard Total Stock Market Index Fund | 1.61M | 1.94% |
| Vanguard Extended Market Index Fund | 600.18K | 0.72% |
| HealthInvest Sustainable Healthcare | 593.96K | 0.72% |
| iShares Biotechnology ETF | 392.71K | 0.47% |
| HealthInvest Alpha Fund | 372.50K | 0.45% |
Insider trades
Form 4 filings by officers, directors and large holders
Over the last 6 months, insiders sold $107.10K (1 trade) of PYXS on the open market, with no buys.
| Insider | Type | Shares | Value |
|---|---|---|---|
| GordonMD Global Investments LP | Buy | 7.17M | — |
| GordonMD Global Investments LP | Buy | 7.55M | — |
| GordonMD Global Investments LP | Buy | 5.52M | — |
| Civik Thomas | Award | 2.50M | — |
| Dupont Jakob | Award | 46.00K | — |
| Civik Thomas | Award | 250.96K | — |
| Dupont Jakob | Option exercise | 35.00K | — |
| Dupont Jakob | Sale | 35.00K | $107.10K |
| Dupont Jakob | Option exercise | 35.00K | $56.00K |
Short interest
Settled Sep 30, 2026
- Shares short
- 4.89M
- Days to cover
- 4.05
- % of shares outstanding
- 5.89%
- Average daily volume
- 1.21M
- Change since last report
- +4.4%
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.